Cardiovascular Diseases Research in Tennessee
Cardiovascular Diseases Research (93.837) awarded $379 million to recipients in Tennessee in 281 grants from fiscal 2021 to 2025, 2.6% of the program's national total. Vanderbilt University Medical Center received the most, $290 million.
- Awarded in Tennessee$379 million
- Awards281
- Share of the program2.6%
- Rank among states13th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 142 | $67.8 million |
| FY 2022 | 148 | $73.8 million |
| FY 2023 | 149 | $74.1 million |
| FY 2024 | 144 | $80.2 million |
| FY 2025 | 143 | $83.5 million |
Recipients in Tennessee
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Vanderbilt University Medical Center | Nonprofits | 182 | $290 million |
| University of Tennessee | Colleges and universities | 23 | $28.4 million |
| St Jude Children's Research Hospital Inc | Nonprofits | 19 | $26.0 million |
| Vanderbilt University | Colleges and universities | 43 | $21.9 million |
| East Tennessee State University | Colleges and universities | 5 | $5.6 million |
| Volumetrix Inc. | Small businesses | 1 | $3.4 million |
| Corami Biotech, Inc. | Small businesses | 1 | $1.3 million |
| Meharry Medical College | Colleges and universities | 2 | $1.2 million |
| University of Tennessee | Colleges and universities | 1 | $687,020 |
| Daxor Corporation | Small businesses | 1 | $512,324 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Tennessee?
$379 million from fiscal 2021 to 2025, across 281 awards. Tennessee ranks 13th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Tennessee?
The largest recipient is Vanderbilt University Medical Center, with $290 million in 182 awards. Next are University of Tennessee and St Jude Children's Research Hospital Inc.
Can organizations in Tennessee apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Tennessee
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Head Start